Evidence map›Paper›PMID 27965758›Full record

ArticleAsthma research and practice2015

The patient with rhinitis in the pharmacy. A cross-sectional study in real life.

Carlo Lombardi, Eleonora Musicco, Francesco Rastrelli, Germano Bettoncelli, Giovanni Passalacqua, Giorgio Walter Canonica

Open access · goldAbstract read
In one paragraph

Article in Asthma research and practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Asthma research and practice: a new journey begins.Asthma research and practice · 2015
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Carlo LombardiUnit of Allergy-Clinical Immunology & Respiratory Diseases - Department of Medicine & Geriatrics, Poliambulanza Hospital Institute, Brescia, Italy.
Eleonora MusiccoUnit of Allergy-Clinical Immunology & Respiratory Diseases - Department of Medicine & Geriatrics, Poliambulanza Hospital Institute, Brescia, Italy.
Francesco RastrelliPresident of the Order of Pharmacists of Brescia, Brescia, Italy.
Germano BettoncelliGeneral Practitioner, Brescia, National Responsible for the Pulmonology Area of the Italian Society of General Practitioners (SIMMG), Brescia, Italy.
Giovanni PassalacquaAllergy & Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Giorgio Walter CanonicaAllergy & Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Fondazione Poliambulanza Istituto Ospedaliero · ITUniversity of Genoa · ITSocietà Italiana di Medicina Generale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the practical management of allergic rhinitis (AR), pharmacists are usually the first-line contact, also because some medications are available as over the counter. Therefore, pharmacists may represent an important resource, in mediating the interaction between patients and physicians. We evaluated the clinical/demographic characteristics of patients with respiratory allergies who consulted their pharmacists as first-line contact. A patient-oriented questionnaire was developed by a scientific committee including pharmacists, GPs, allergists, pulmonologists and ENT specialists.

methodsThe questionnaire consisted of items covering the general aspects of AR. Allergic Rhinitis and its Impact on Asthma guidelines were assumed as reference for diagnosis and therapy. The questionnaire was distributed to pharmacies, and pharmacists were asked to deliver the questionnaire to all patients referring for nasal symptoms.

results30 pharmacies were involved during the pollen season 2011, and 410 patients (55 % male) participated. The most frequent complaints were 20 rhinitis (49 %) and conjunctivitis (29 %), followed by lower respiratory symptoms (cough and/or dyspnea). Isolated conjunctival symptoms were present in only 22 % of patients. Among patients with lower respiratory symptoms, cough was the most frequent, variously associated with upper respiratory symptoms or overt dyspnea. Dyspnea alone was present in 16 % of patients. 39 % of patients had no physician-based diagnosis. Oral antihistamines were the most used self-medication, followed by intranasal decongestants. 30 % of respondents had used alternative medicines.

conclusionAccording to these data, AR is still considered a trivial disease, frequently self-managed, with over the counter medications, not in line with guidelines. A physician-based diagnosis is present in about 60 % of patients.

Indexed as

Allergic asthmaAllergic rhinitisPharmacistRespiratory allergy

Identifiers

PMID27965758
PMCPMC4970378
OpenAlexW2101150816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.